Integra LifeSciences Corporation
IART | NASDAQ
$16.09
+$0.50 (+3.21%)
Sep 22, 2026, 11:13 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -1.85 | -251.44 | 50.06 | 25.72 | 33.49 | 41.09 |
PEG Ratio | 0 | 2.28 | -0.83 | 2.86 | 1.26 | 0.24 |
PS Ratio | 0.58 | 1.08 | 2.21 | 2.99 | 3.68 | 4.01 |
PB Ratio | 0.91 | 1.13 | 2.14 | 2.58 | 3.37 | 3.63 |
P/FCF Ratio | -21.06 | 69.96 | 46.58 | 21.41 | 21.46 | 39.27 |
P/OCF Ratio | 18.92 | 13.50 | 24.32 | 17.60 | 18.16 | 26.96 |
OCF/S Ratio | 3.08 | 8.03 | 9.08 | 16.98 | 20.26 | 14.86 |
Debt / Equity Ratio | 1.95 | 1.28 | 1.06 | 0.90 | 0.99 | 1.09 |
Quick Ratio | 1.46 | 0.71 | 2.18 | 2.61 | 2.46 | 2.31 |
Current Ratio | 2.54 | 1.17 | 3.45 | 3.62 | 3.39 | 3.09 |
Asset Turnover | 0.45 | 0.40 | 0.41 | 0.40 | 0.41 | 0.38 |
Interest Coverage | 0.79 | 0.40 | 2.17 | 4.82 | 3.91 | 2.11 |
Return on Equity | -49.50% | -0.45% | 4.27% | 10.01% | 10.04% | 8.84% |
Return on Assets | -14.34% | -0.17% | 1.79% | 4.64% | 4.47% | 3.70% |
Return on Invested Capital | 1.91% | 0.29% | 2.66% | 5.55% | 4.42% | 4.49% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 51.69% | 54.77% | 57.39% | 62.29% | 61.24% | 62.03% |
Net Profit Margin | -31.58% | -0.43% | 4.39% | 11.59% | 10.96% | 9.76% |
Pretax Profit Margin | -34.46% | -1.13% | 5.26% | 13.73% | 13.92% | 6.82% |
Operating Profit Margin | 4.18% | 1.76% | 7.23% | 15.34% | 12.79% | 11.03% |
FCF Margin | -2.77% | 1.55% | 4.74% | 13.96% | 17.14% | 10.20% |
EBITDA Margin | -19.95% | 12% | 16.60% | 24.69% | 23.75% | 19.53% |
Add to Watchlist
Select watchlists to add or remove IART